Measurement of urinary concentrations of ultraviolet filters in bio-banked urine
Public summary
Generated or condensed from imported source text. Verify before bidding.
**Tender summary:** Health Canada is seeking an external laboratory to measure concentrations of eight ultraviolet (UV) filters in urine samples from children and adolescents. The work is intended to support biomonitoring, health-risk assessment, and possible scientific publications. **What the work appears to involve:** - Analysing urine biospecimens from the MIREC ENDO biobank. - Starting with samples from MIREC ENDO Phase 1, with possible later testing of Phase 2 or other biobank samples depending on results and approvals. - Providing reliable measurements and supporting sample tracking and handling. - Working within the approval requirements of the MIREC Biobank management committee, including scientific validity, laboratory expertise, and minimizing the sample volume used. **Important requirements and constraints:** - The contractor must be an ISO-accredited laboratory. - The laboratory must participate in proficiency-testing or quality-assurance programs, such as CALA or an equivalent international program. - Samples cannot be transported outside Canada, so the testing facility and sample-handling arrangements would need to remain in Canada. - The project may require experience with receiving, tracking, and analysing biobanked human urine specimens. **Buyer:** Department of Health (Health Canada) **Status:** Open **Closing date:** October 1, 2026, at 2:00 p.m. The tender record does not state the time zone, so this should be confirmed in the official notice. This opportunity appears potentially relevant to Canadian ISO-accredited laboratories with suitable biomonitoring, analytical chemistry, and biobank-sample experience. The information provided does not establish that any particular business qualifies. Review the full official tender document for submission instructions, mandatory criteria, analytical methods, security or privacy requirements, pricing details, and the applicabletime zone before deciding whether to bid: https://canadabuys.canada.ca/sites/default/files/webform/tender_notice/107042/1000273182_acan-%28final-en.pdf
Requirement preview
A profile unlocks the full bid checklist and match explanation.
- The contractor must be ISO accredited.
- The contractor must participate in proficiency-testing or quality-assurance regimes, such as Canadian Association for Laboratory Accreditation (CALA) proficiency testing or an international accreditation program.
- Samples cannot be transported outside Canada; the work and sample handling must therefore support retention of samples within Canada.
- The work involves analysis of a suite of 8 ultraviolet filters in urine biospecimens from the MIREC ENDO biobank, including preadolescent and adolescent samples.
Source description preview
Imported source text may contain formatting from the original notice.
Ultraviolet (UV) filters are a class of high production chemicals used in numerous personal care products including sunscreen and cosmetics to absorb and filter UV radiation. They are also used in numerous products such as plastics to minimize deterioration or discoloration due to UV radiation. These chemicals are potential endocrine disrupters and some have demonstrated reproductive and developmental toxicity in experimental studies. Biomonitoring data in humans have largely focused on benzophenone-3 (BP-3), the chemical most commonly added to sunscreen, and data are notably limited for children and adolescents. Little is known about potential reproductive toxicity. Understanding levels of these chemicals in children just before and during puberty may be important as they may be more sensitive to the impacts of endocrine disruption. This project will generate biomonitoring data for a suite of 8 UV filters in children. We will leverage the available urine biospecimens from the Maternal-Infant Research on Environmental Chemicals biobank to conduct this research and generate novel biomonitoring data on UV filters in preadolescents and adolescents. This will address notable gaps in available biomonitoring data, we will generate data for Health Canada risk assessors, and for publication in the scientific literature. UV filters have been identified as a chemical class of interest and several of our target analytes, have been specifically identified as emerging risk assessment candidates. Constraints on the work include the constraints associated with approval to access biobanked urine specimens from the MIREC ENDO Study. The MIREC Biobank management committee approves the release of biospecimens for analysis by external laboratories. Key considerations for that approval are (1) scientific validity; (2) location/expertise of laboratory (experience receiving and tracking samples); (3) sample volume required. Additional constraints are the phased approach to analysis, where the first phase of the analysis will be analysis of urine from MIREC ENDO Phase 1. Depending on frequency of detection, and overall quality of the results delivered, then the second phase will be approved to measure the UV-filters in biospecimens from Phase 2 of MIREC ENDO. Finally, depending on the needs of risk assessors and the availability of biospecimens from other biobanks, additional analyses may be undertaken. The contractor must be ISO accredited and participate in proficiency/quality regimes, such as the Canadian Association for Laboratory Accreditation (CALA) proficiency testing or international accreditation programs. NOTE - SAMPLES CAN'T BE TRANSPORTED OUTSIDE OF CANADA
Turn this listing into a bid decision.
Build a company profile to unlock match scoring, explanations, checklist next steps, saved opportunity tracking, and alerts.